Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BMRN
Therapeutics Stocks Q2 Results: Benchmarking BioMarin Pharmaceutical (NASDAQ:BMRN) StockStory - Wed Aug 19, 10:31PM CDT

Therapeutics Stocks Q2 Results: Benchmarking BioMarin Pharmaceutical (NASDAQ:BMRN)

BMRN : 67.68 (-2.38%)
BMRN
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today StockStory - Wed Aug 19, 3:20PM CDT

Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today

BMRN : 67.68 (-2.38%)
BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin's Pipeline PR Newswire - Tue Aug 18, 7:30AM CDT

BioMarin to pay $275 million upfront, plus additional payments upon achievement of development and regulatory milestones

BMRN : 67.68 (-2.38%)
RH
3 Cash-Producing Stocks We Find Risky StockStory - Wed Aug 12, 11:34PM CDT

3 Cash-Producing Stocks We Find Risky

RH : 156.41 (-7.98%)
BMRN : 67.68 (-2.38%)
FSTR : 37.95 (+2.57%)
BMRN
BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know StockStory - Mon Aug 10, 10:50AM CDT

BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know

BMRN : 67.68 (-2.38%)
BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston PR Newswire - Mon Aug 10, 8:05AM CDT

SAN RAFAEL, Calif. , Aug. 10, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced management will present at the Canaccord Genuity 46th Annual Growth Conference on Wednesday,...

BMRN : 67.68 (-2.38%)
BMRN
BioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Impressive Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations StockStory - Thu Aug 6, 3:25PM CDT

BioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Impressive Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations

BMRN : 67.68 (-2.38%)
BioMarin: Q2 Earnings Snapshot AP - Thu Aug 6, 3:23PM CDT

BioMarin: Q2 Earnings Snapshot

BMRN : 67.68 (-2.38%)
BioMarin Reports Second Quarter 2026 Financial and Operating Results PR Newswire - Thu Aug 6, 3:03PM CDT

Second Quarter 2026 Total Revenues Increased 20% Year-over-year to $990 million

BMRN : 67.68 (-2.38%)
BioMarin: Can Amicus Integration Costs Justify What You're Now Paying for Growth? Barchart - Wed Aug 5, 4:04PM CDT

Barchart Research What to Expect from BMRN Earnings BMRN Generated August 5, 2026 Current Price $59.91 EPS Estimate $$0.79 Consensus Rating Moderate Buy Average Move 3.39% BioMarin: Can Amicus Integration...

BMRN : 67.68 (-2.38%)

Barchart Exclusives

Coatue Management Opens New Position in AMD Stock. View This as a Renewed Bet on the AI Trade. Barchart - 7 minutes ago
Coatue Management started a new AMD stock position worth $55.8 million in Q2, joining a wave of fresh AI bets from the hedge fund giant. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.